Posted on

Dindolyl Methane, or DIM as it is commonly referred to, is a very popular supplement used by bodybuilders and others who are interested in increasing the size of their muscles. Recent research has shown that DIM could pose health hazards. For example, DIM can cause serious liver damage if consumed in excess. A related risk is kidney damage, which can lead to kidney failure. Many bodybuilders and athletes are worried about the long-term health risks that come with DIM.

The majority of people take diindolylmethane supplements to boost the production of testosterone. Testosterone has been shown to act as an androgen, which means that it can trigger hormonal changes in tissues. DIM has been demonstrated in studies to mimic the effects of testosterone, and other hormones. Because men produce much more testosterone than women do, some manufacturers have added diindolylmethane into their products in order to boost their competitiveness in male circles. Men will react to products that mimic testosterone naturally.

In the end, numerous companies promote DIM as a cancer-fighter. It’s true that diindolylmethane does reduce tumor growth in laboratory animals, however these animals were administered the drug, not orally. To get the same effect in humans, diindolylmethane has to be consumed in large doses over a prolonged period of time. The animals that were examined had no symptoms of cancer for several years. However, they all developed liver diseases after consuming excessive amounts of diindolylmethane. To get a real glimpse of how DIM works in the body, you should contact a medical practitioner.

According to the US National Institute of Environmental Health Safety and Security, the only way to prove that DIM is effective in treating breast cancer is to conduct an experiment wherein cells from healthy breast cancer cells are exposed to high doses of diindolylmethane over a prolonged period of time. There are pros and negatives to using DIM just like any chemical. The ability to mimic hormones is one of the advantages. This means that you could make insulin, which could stop the proliferation of cancer cells. The cons include the fact diindolylmethane is also able to produce an extremely harmful chemical known as DMSO. Read more about diindolylmethane where to buy now.

One of the most popular claims about diindolylmethane’s usage as a treatment for various diseases is that it is an natural, antibacterial, anti-cancer and anti-fungal agent. The National Institute of Health, through a thorough review of the supporting evidence concluded that there was no basis for these claims. According to the Institute of Chemical Technology, there was no research conducted to prove this claim. The Institute of Chemical Safety, in their in-depth analysis of the safety profile of the firestone concluded that the evidence provided by pharmaceutical companies regarding the benefits of diindolylmethane to humans were not completely reliable.

Van der Goes and. and. published their findings in a May 2021 issue of the Journal of Toxicology and Environmental Health. Van der Goes, and., highlighted the potential dangers of diindolylmethane use, including allergic reactions to the skin asthma attacks, as well as dizziness, headaches and respiratory problems. The daily dosage recommended for this chemical, which is roughly one tenth of a teaspoon, was 0.2 milligrams. It is unclear how much concentration it will have when this chemical is mixed with other compounds. Since this substance hasn’t been thoroughly tested, it cannot be considered to be safe at any level.

The abstract of the view shows that diindolylmethane’s use in cancer treatment is based on the notion that intracellular inhibition of pyruvate metabolism via flavenoids can be inhibited and stops the accumulation of Oxalates and pyruvate-derived metabolites in renal tubule cells. However, the drug metabiplicate toxicology studies didn’t provide convincing evidence that consumption of this chemical can cause an overdose. The Food and Drug Administration approved this substance as a prescribed drug in June 1996. According to the FDA, the manufacturer of firestone tincture is in the process of conducting two major studies – one in Europe and another in the United States.

The view abstract also shows that diindolylmethane’s usage in the treatment of cancer is based on the concept of inhibiting intracellular inhibition via flavenoids of pyruvate metabolism and thus preventing the accumulation of oxalates and adenine in renal tubule cells. However, the drug metabiplicate toxicology studies did not provide convincing evidence that the consumption of this chemical can cause an overdose. In June 1996, the Food and Drug Administration approved this drug as a prescribed drug. According to the FDA the manufacturer of firestone Tincture is currently conducting two major trials in Europe and the United States. According to FDA, the FDA states that the manufacturer of the tincture is currently conducting two major trials in Europe and one in the United States.